author-photo

Wenpeng Li

Baylor College of Medicine

4

Papers

34

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

A phase I clinical trial using armored GPC3 CAR T cells for children with relapsed/refractory liver tumors.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Redirecting T cells to glypican-3 with 4-1BB zeta chimeric antigen receptors results in Th1 polarization and potent antitumor activity

2017 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (26)
Redirecting T cells to Glypican-3 with 4-1BB.ζ CAR results in Th-1 polarization and potent anti-tumor activity.

2016 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (4)
416. Immunotherapy of Hepatocellular Carcinoma With T Cells Engineered To Express Glypican-3-Specific Chimeric Antigen Receptors

2015 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (1)